Immunogenicity study of glycoprotein-deficient rabies virus expressing simian/human immunodeficiency virus SHIV89.6P envelope in a rhesus macaque

Journal of Virology

Volumn 78, Issue 24, 2004, Pages 13455-13459

  McKenna, Philip M ^a   Aye, Pyone Pyone ^b   Dietzschold, Bernhard ^a   Montefiori, David C ^c   Martin, Louis N ^b   Marx, Preston A ^b   Pomerantz, Roger J ^a   Lackner, Andrew ^b   Schnell, Matthias J ^a,d  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS PROTEIN; VIRUS RNA;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RABIES VIRUS; RHABDOVIRUS; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIREMIA; VIRUS ENVELOPE; VIRUS REPLICATION;

AIDS VACCINES; ANIMALS; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; GENE DELETION; GENE PRODUCTS, ENV; GLYCOPROTEINS; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; MACACA MULATTA; RABIES VIRUS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VIRAL ENVELOPE PROTEINS;

EID: 10044249138     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.24.13455-13459.2004     Document Type: Article

References (21)

1. Amara, R. R., F. Villinger, J. D. Altman, S. L. Lydy, S. P. O'Neil, S. I. Staprans, D. C. Montefiori, Y. Xu, J. G. Herndon, L. S. Wyatt, M. A. Candido, N. L. Kozyr, P. L. Earl, J. M. Smith, H.-L. Ma, B. D. Grimm, M. L. Hulsey, J. Miller, H. M. McClure, J. M. McNicholl, B. Moss, and H. L. Robinson. 2001. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292:69-74.
2. Barouch, D., J. Kunstman, M. Kuroda, J. Schmilz, S. Santra, F. Peyerl, G. Krivulka, K. Beaudry, M. Lifton, D. Gorgone, D. Montefiori, M. Lewis, S. Wolinsky, and N. Letvin. 2002. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415:335-339.
3. Barouch, D. H., T. M. Fu, D. C. Montefiori, M. G. Lewis, J. W. Shiver, and N. L. Letvin. 2001. Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeys. Immunol. Lett. 79:57-61.
4. Barouch, D. H., J. Kunstman, J. Glowczwskie, K. J. Kunstman, M. A. Egan, F. W. Peyerl, S. Santra, M. J. Kuroda, J. E. Schmitz, K. Beaudry, G. R. Krivulka, M. A. Lifton, D. A. Gorgone, S. M. Wolinsky, and N. L. Letvin. 2003. Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys. J. Virol. 77:7367-7375.
5. Barouch, D. H., S. Santra, J. E. Schmitz, M. J. Kuroda, T.-M. Fu, W. Wagner, M. Bilska, A. Craiu, X. X. Zheng, G. R. Krivulka, K. Beaudry, M. A. Liftom, C. E. Nickerson, W. L. Trigona, K. Punt, D. C. Freed, L. Guan, S. Dubey, D. Casimoro, A. Simon, M.-E. Davies, M. Chastain, T. B. Strom, R. S. Gelman, D. C. Montefiori, M. G. Lewis, E. A. Emini, J. W. Shiver, and N. L. Letvin. 2000. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 290:486-492.
6. Boritz, E., J. Gerlach, J. E. Johnson, and J. K. Rose. 1999. Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway. J. Virol. 73:6937-6945.
7. Crawford, J. M., P. Earl, B. Moss, R. C. Reichman, M. Wyand, K. Manson, M. Bilska, J. Zhou, C. D. Pauza, P. W. Parren, D. R. Burton, J. Sodroski, N. Letvin, and D. Montefiori. 1999. Characterization of primary isolate-like variants of simian immunodeficiency virus. J. Virol. 73:10199-10207.
8. Foley, H. D., M. Otero, J. M. Orenstein, R. J. Pomerantz, and M. J. Schnell. 2002. Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1) envelopes display HIV-1-like tropism and target human dendritic cells. J. Virol. 76:19-31.
9. Kelley, J. M., S. U. Emerson, and R. R. Wagner. 1972. The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody. J. Virol. 10:1231-1235.
10. McKenna, P. M., R. J. Pomerantz, B. Dietzschold, J. P. McGettigan, and M. J. Schnell. 2003. Covalently linked human immunodeficiency virus type 1 gp120/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopes. J. Virol. 77:12782-12794.
11. Mebatsion, T., S. Finke, F. Weiland, and K.-K. Conzelmann. 1997. A CXCR4/CD4 pseudotype rhabdovirus that selectively infects HIV-1 envelope protein-expressing cells. Cell 90:841-547.
12. Moretto, W. J., L. A. Drohan, and D. F. Nixon. 2000. Rapid quantification of SIV-specific CD8 T cell responses with recombinant vaccinia virus ELISPOT. AIDS 14:2625-2627.
13. Reimann, K. A., J. T. Li, R. Veazey, M. Halloran, I.-W. Park, G. B. Karlsson, J. Sodroski, and N. L. Letvin. 1996. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J. Virol. 70:6922-6928.
14. Richardson, T. M., Jr., B. L. Stryjewski, C. C. Broder, J. A. Hoxie, J. R. Mascola, P. L. Earl, and R. W. Doms. 1996. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein. J. Virol. 70:753-762.
15. Roberts, A., L. Buonocore, R. Price, J. Forman, and J. K. Rose. 1999. Attenuated vesicular stomatitis viruses as vaccine vectors. J. Virol. 73:3723-3732.
16. Rose, N. F., P. A. Marx, A. Luckay, D. F. Nixon, W. J. Moretto, S. M. Donahoe, D. Montefiori, A. Roberts, L. Buonocore, and J. K. Rose. 2001. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell 106:539-549.
17. Schnell, M. J., J. E. Johnson, L. Buonocore, and J. K. Rose. 1997. Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell 90:849-857.
18. Shacklett, B. L., B. Ling, R. S. Veazey, A. Luckay, W. J. Moretto, D. T. Wilkens, J. Hu, Z. R. Israel. D. F. Nixon, and P. A. Marx. 2002. Boosting of SIV-specific T cell responses in rhesus macaques that resist repeated intravaginal challenge with SIVmac251. AIDS Res. Hum. Retrovir. 18:1081-1088.
19. Shiver, J., T. Fu, L. Chen, D. Casimiro, M. Davies, R. Evans, Z. Zhang, A. Simon, W. Trigona, S. Dubey, L. Huang, V. Harris, R. Long, X. Liang, L. Handt, W. Schleif, L. Zhu, D. Freed, N. Persaud, L. Guan, K. Punt, A. Tang, M. Chen, K. Wilson, K. Collins, G. Heidecker, V. Fernandez, H. Perry, J. Joyce, K. Grimm, J. Cook, P. Keller, D. Kresock, H. Mach, R. Troutman, L. Isopi, D. Williams, Z. Xu, K. Bohannon, D. Volkin, D. Montefiori, A. Miura, G. Krivulka, M. Lifton, M. Kuroda, J. Schmitz, N. Letvin, M. Caulfield, A. Bett, R. Youil, D. Kaslow, and E. Emini. 2002. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415:331-335.
20. Wiktor, T. J., E. Gyorgy, D. Schlumberger, F. Sokol, and H. Koprowski. 1973. Antigenic properties of rabies virus components. J. Immunol. 110:269-276.
21. Yeghiazarian, T., Y. Zhao, S. E. Read, W. Kabat, X. Li, S. J. Hamren, P. J. Sheridan, J. C. Wilher, D. N. Chernoff, and R. Yogev. 1998. Quantification of human immunodeficiency virus type 1 RNA levels in plasma by using small-volume-format branched-DNA assays. J. Clin. Microbiol. 36:2096-2098.